Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057109335675v1
14/7/769    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hollands, E. C.
Right arrow Articles by Trezise, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hollands, E. C.
Right arrow Articles by Trezise, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Population Patch-Clamp Electrophysiology Analysis of Recombinant GABAA {alpha}1β3{gamma}2 Channels Expressed in HEK-293 Cells

Emma C. Hollands

Biochemical & Cellular Targets, Molecular Discovery Research, GlaxoSmithKline R&D, Harlow, Essex, United Kingdom

Tim J. Dale

Biochemical & Cellular Targets, Molecular Discovery Research, GlaxoSmithKline R&D, Harlow, Essex, United Kingdom

Andrew W. Baxter

Biochemical & Cellular Targets, Molecular Discovery Research, GlaxoSmithKline R&D, Harlow, Essex, United Kingdom

Helen J. Meadows

Biochemical & Cellular Targets, Molecular Discovery Research, GlaxoSmithKline R&D, Harlow, Essex, United Kingdom

Andrew J. Powell

Biochemical & Cellular Targets, Molecular Discovery Research, GlaxoSmithKline R&D, Harlow, Essex, United Kingdom

Jeff J. Clare

Biochemical & Cellular Targets, Molecular Discovery Research, GlaxoSmithKline R&D, Harlow, Essex, United Kingdom

Derek J. Trezise

Biochemical & Cellular Targets, Molecular Discovery Research, GlaxoSmithKline R&D, Harlow, Essex, United Kingdom, derek.j.trezise{at}gsk.com

{gamma}-Amino butyric acid (GABA)—activated Cl channels are critical mediators of inhibitory postsynaptic potentials in the CNS. To date, rational design efforts to identify potent and selective GABAA subtype ligands have been hampered by the absence of suitable high-throughput screening approaches. The authors describe 384-well population patch-clamp (PPC) planar array electrophysiology methods for the study of GABAA receptor pharmacology. In HEK293 cells stably expressing human {alpha}1β3{gamma}2 GABAA channels, GABA evoked outward currents at 0 mV of 1.05 ± 0.08 nA, measured 8 s post GABA addition. The IGABA was linear and reversed close to the theoretical ECl (—56 mV). Concentration-response curve analysis yielded a mean pEC50 value of 5.4 and Hill slope of 1.5, and for a series of agonists, the rank order of potency was muscimol > GABA > isoguvacine. A range of known positive modulators, including diazepam and pentobarbital, produced concentration-dependent augmentation of the GABA EC 20 response (1 µM). The competitive antagonists bicuculline and gabazine produced concentration-dependent, parallel, rightward displacement of GABA curves with pA2 and slope values of 5.7 and 1.0 and 6.7 and 1.0, respectively. In contrast, picrotoxin (0.2-150 µM) depressed the maximal GABA response, implying a non-competitive antagonism. Overall, the pharmacology of human {alpha}1β3{gamma}2 GABAA determined by PPC was highly similar to that obtained by conventional patch-clamp methods. In small-scale single-shot screens, Z' values of >0.5 were obtained in agonist, modulator, and antagonist formats with hit rates of 0% to 3%. The authors conclude that despite the inability of the method to resolve the peak agonist responses, PPC can rapidly and usefully quantify pharmacology for the {alpha}1β3{gamma}2 GABAA isoform. These data suggest that PPC may be a valuable approach for a focused set and secondary screening of GABAA receptors and other slow ligand-gated ion channels. ( Journal of Biomolecular Screening 2009:769-780)

Key Words: Population patch clamp • {gamma}-amino-butyric acid • planar array electrophysiology • bicuculline

This version was published on August 1, 2009

Journal of Biomolecular Screening, Vol. 14, No. 7, 769-780 (2009)
DOI: 10.1177/1087057109335675


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?